SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-22-000087
Filing Date
2022-10-14
Accepted
2022-10-14 19:02:33
Documents
1
Period of Report
2022-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166578850300322.html 4  
1 FORM 4 wf-form4_166578850300322.xml 4 4459
  Complete submission text file 0001479290-22-000087.txt   5868
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ZELTIQ AESTHETICS INC. 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588
Business Address
Foley Mark J (Reporting) CIK: 0001529196 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 221312340